Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Zurzuvae
Zurzuvae
Sage’s recent trial failure adds pressure to its two-drug Biogen collab
Pharma Voice
Mon, 07/29/24 - 10:29 am
SAGE Therapeutics
Biogen
clinical trials
SAGE-324
essential tremor
Zurzuvae
postpartum depression
Biogen sees ‘encouraging’ trends for postpartum depression drug
BioPharma Dive
Wed, 04/24/24 - 09:18 pm
Biogen
postpartum depression
Zurzuvae
Sage offers encouraging details on launch of new postpartum depression pill
BioPharma Dive
Wed, 02/14/24 - 06:42 pm
SAGE Therapeutics
postpartum depression
drug launches
Zurzuvae
Biogen-Sage Therapeutics postpartum depression pill priced at $15,900
Reuters
Tue, 11/7/23 - 09:55 am
Biogen
SAGE Therapeutics
postpartum depression
drug pricing
Zurzuvae
Biogen, Sage's postpartum depression approval overshadowed by larger rejection
Fierce Pharma
Mon, 08/7/23 - 12:01 pm
SAGE Therapeutics
Biogen
FDA
Zurzuvae
postpartum depression
major depressive disorder
FDA Approves Biogen, Sage’s Zurzuvae as First Pill for Postpartum Depression
BioSpace
Sun, 08/6/23 - 09:39 pm
Biogen
SAGE Therapeutics
FDA
Zurzuvae
postpartum depression
major depressive disorder
zuranolone
